Shares Magazine
69.61p+5.21 (+8.09%)19 Apr 2024, 10:21
Jump to:
Novacyt S.A. Fundamentals
| Company Name | Novacyt S.A. | Last Updated | 2024-04-19 |
|---|---|---|---|
| Industry | Medical Devices | Sector | Healthcare |
| Shares in Issue | 70.626 m | Market Cap | £49.16 m |
| PE Ratio | 1.19 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.36 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.0029 | Debt Equity Ratio | 0.0020 |
| Asset Equity Ratio | 1.2315 | Cash Equity Ratio | 0.7617 |
| Quick Ratio | 4.5341 | Current Ratio | 5.09 |
| Price To Book Value | 0.4239 | ROCE | 0 |
Novacyt S.A. Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Novacyt S.A. Company Financials
| Assets | 2022 | 2021 |
|---|---|---|
| Tangible Assets | £3.27 m | £6.38 m |
| Intangible Assets | £9.77 m | £15.18 m |
| Investments | 0 | £144,000.00 |
| Total Fixed Assets | £13.66 m | £24.91 m |
| Stocks | £3.03 m | £11.46 m |
| Debtors | £25.35 m | £30.29 m |
| Cash & Equivalents | £86.98 m | £101.75 m |
| Other Assets | £624,000.00 | £3.21 m |
| Total Assets | £140.90 m | £183.70 m |
| Liabilities | 2022 | 2021 |
|---|---|---|
| Creditors within 1 year | £24.24 m | £38.90 m |
| Creditors after 1 year | £1.45 m | £2.98 m |
| Other Liabilities | 0 | 0 |
| Total Liabilities | £25.68 m | £41.88 m |
| Net assets | £115.22 m | £141.81 m |
| Equity | 2022 | 2021 |
|---|---|---|
| Called up share capital | £4.05 m | £4.05 m |
| Share Premium | £50.67 m | £50.67 m |
| Profit / Loss | -£20.05 m | -£5.66 m |
| Other Equity | £115.22 m | £141.81 m |
| Preference & Minorities | 0 | 0 |
| Total Capital Employed | £115.22 m | £141.81 m |
| Ratios | 2022 | 2021 |
|---|---|---|
| Debt Ratio | £0.00 | £0.01 |
| Debt-to-Equity | £0.00 | £0.01 |
| Assets / Equity | 1.2315 | 1.2315 |
| Cash / Equity | 0.7617 | 0.7617 |
| EPS | -£0.31 | -£0.10 |
| Cash Flow | 2022 | 2021 |
|---|---|---|
| Cash from operating activities | -£13.73 m | £15.69 m |
| Cashflow before financing | -£14.24 m | £15.05 m |
| Increase in Cash | -£14.82 m | £10.06 m |
| Income | 2022 | 2021 |
|---|---|---|
| Turnover | £21.04 m | £92.60 m |
| Cost of sales | £15.29 m | £64.38 m |
| Gross Profit | £5.75 m | £28.23 m |
| Operating Profit | -£23.39 m | -£3.92 m |
| Pre-Tax profit | -£20.05 m | -£5.66 m |
Novacyt S.A. Company Background
| Sector | Healthcare |
|---|---|
| Activities | Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment. |
| Latest Interim Date | 28 Sep 2023 |
| Latest Fiscal Year End Date | 26 Apr 2024 |
Novacyt S.A. Directors
| Appointed | Name | Position |
|---|---|---|
| 2021-07-29 | Mr. Graham D. Mullis | Executive Director,Chief Executive Officer |
| 2023-05-26 | Dr. Andrew John William Heath | Non-Executive Director,Senior Independent Director |
| 2022-12-07 | Dr. Edwin Snape | Non-Executive Director |
| 2023-05-26 | Mr. Anthony Stephen Dyer | Executive Director,Chief Corporate Development Officer (CCDO). Both appointments are with immediate effect. |
| 2023-05-26 | Mr. James Christopher Wakefield | Non-Executive Director,Chairman |
| 2023-05-26 | Mr. Jean-Pierre Jacques Crinelli | Non-Executive Director |
| 2022-11-10 | Mr. David James Allmond | Executive Director,Chief Executive Officer |
Novacyt S.A. Contact Details
| Company Name | Novacyt SA |
|---|---|
| Address | 13, Avenue Morane Saulnier, Velizy-Villacoublay, 78140 |
| Telephone | +33 139465104 |
| Website | https://www.novacyt.com |
Novacyt S.A. Advisors
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Ferrexpo PLC | 47.60 | 2.15 |
| Hochschild Mining PLC | 153.40 | 1.59 |
| Darktrace PLC | 464.60 | 1.35 |
| Croda International PLC | 4,894.00 | 0.93 |
| Endeavour Mining PLC | 1,744.00 | 0.93 |
| United Utilities Group PLC | 1,027.50 | 0.88 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Man Group PLC | 255.00 | -5.06 |
| Jd Sports Fashion PLC | 116.13 | -3.47 |
| Discoverie Group PLC | 669.00 | -3.18 |
| Intermediate Capital Group PLC | 1,964.00 | -2.96 |
| Scottish Mortgage Investment Trust PLC | 800.60 | -2.86 |
| Jupiter Fund Management PLC | 79.42 | -2.67 |